|
Volumn 38, Issue 4, 2001, Pages 932-938
|
Metoprolol controlled release/extended release in patients with severe heart failure: Analysis of the experience in the MERIT-HF study
|
Author keywords
[No Author keywords available]
|
Indexed keywords
METOPROLOL;
PLACEBO;
ADULT;
ADVERSE DRUG REACTION;
AGED;
ARTICLE;
CAUSE OF DEATH;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED DRUG RELEASE;
CONTROLLED RELEASE FORMULATION;
CONTROLLED STUDY;
DISEASE SEVERITY;
DRUG EFFECT;
DRUG EFFICACY;
DRUG TOLERABILITY;
FEMALE;
FOLLOW UP;
FUNCTIONAL ASSESSMENT;
HEART FAILURE;
HEART LEFT VENTRICLE EJECTION FRACTION;
HOSPITALIZATION;
HUMAN;
MAJOR CLINICAL STUDY;
MALE;
MORTALITY;
MULTICENTER STUDY;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
SINGLE BLIND PROCEDURE;
SUDDEN DEATH;
ADRENERGIC BETA-ANTAGONISTS;
ADULT;
AGED;
AGED, 80 AND OVER;
DELAYED-ACTION PREPARATIONS;
FEMALE;
HEART FAILURE, CONGESTIVE;
HOSPITALIZATION;
HUMANS;
MALE;
METOPROLOL;
MIDDLE AGED;
MULTICENTER STUDIES;
RANDOMIZED CONTROLLED TRIALS;
|
EID: 0034814619
PISSN: 07351097
EISSN: None
Source Type: Journal
DOI: 10.1016/S0735-1097(01)01516-9 Document Type: Article |
Times cited : (129)
|
References (9)
|